Factors associated with molecular diagnosis for COVID-19: a cross-sectional study, Espírito Santo/Brazil

Authors

  • João Paulo Cola Laboratorio de Epidemiologia - UFES https://orcid.org/0000-0003-4972-4686
  • Thiago Nascimento do Prado Universidade Federal do Espirito Santo https://orcid.org/0000-0001-8132-6288
  • Heletícia Scabelo Galavote Universidade Federal do Espirito Santo - CEUNES
  • Cathiana do Carmo Dalto Banhos Universidade Federal do Espirito Santo - CEUNES
  • Ana Carolina Giobini Micaela Universidade Federal do Espirito Santo - CEUNES https://orcid.org/0000-0001-8660-8356
  • Ramylle Mayse dos Santos Universidade Federal do Espirito Santo - CEUNES
  • Ethel Leonor Noia Maciel Universidade Federal do Espirito Santo https://orcid.org/0000-0003-4826-3355

DOI:

https://doi.org/10.36311/jhgd.v33.13568

Keywords:

COVID-19, COVID-19 Nucleic Acid Testing, COVID-19 Testing, Cross-Sectional Studies.

Abstract

Backgroung: Brazil was slow to implement an expanded testing policy for COVID-19, which may have affected the most vulnerable population’s access to testing services.
Objective: to evaluate the factors associated with performing the molecular test for COVID-19.

Methods: cross-sectional study of secondary data from the COVID-19 panel in the state of Espírito Santo. COVID-19 suspicion notification forms were included between September 11, 2020 and March 2, 2021. Hierarchical logistic regression was used to estimate the odds ratio (OR) with 95% confidence interval (CI95%).

Results: 419,771 notification forms were analyzed. The prevalence of performing the molecular teste for COVID-19 was 81.1% (CI95% 81.0-81.2). Elderly (OR= 2.70 – CI95% 2.56-2.85), health professional (OR=1 .43 – CI95% 1.36-1.50), chronic cardiovascular disease (OR=1.13 – CI95% 1.09-1.17), diabetes mellitus (OR=1.07 – CI95% 1.01- 1.14) and hospitalization (OR=5.95 – CI95% 4.53;7.82) were more likely to have undergone the molecular test. Male sex (OR=0.96 – CI95% 0.94-0.98), black skin color (OR=0.75 – CI95% 0.73-0.78), yellow skin color (OR=0.74 – CI95% 0.71-0.77), residing in the northern health region (OR=0.37 – CI95% 0.36-0.39) and the homeless population (OR=0.76 – CI95% 0.67-0.85) had the lowest chance of having undergone the molecular test.

Conclusion: Social, economic, contextual factors and the risk of aggravation of the disease were associated with carrying out the molecular test for COVID-19 in the state of Espírito Santo. Actions are needed to guarantee the access of the most vulnerable population to molecular testing.

Downloads

Download data is not yet available.

References

Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico Especial – 106. Doença pelo novo Coronavírus – COVID-19. Secretaria de Vigilância em Saúde. Brasília-DF. 2022.

Sousa CDK, Morais TC, Daboin BEG, Portugal I, Calvalcanti MPE, Echeimberg JO, et al. Perfil epidemiológico da COVID-19 no Estado do Espírito Santo, Brasil, de março de 2020 a junho de 2021. J Hum Growth Dev. 2021; 31(3):507-520. doi: 10.36311/jhgd.v31.12770

Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, Dittrich S, Yansouni CP. Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review. Annals of Internal Medicine. 2020; 172(11): 726-734. DOI: 10.7326/M20-1301

Castro R, Luz PM, Wakimotoc MD, Velosoc VG, Grinsztejnc B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Brazilian Journal of Infectious Diseases. 2020; 24(2): 180-187. DOI: 10.1016/j.bjid.2020.04.003

Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021; 49(1): 21-29. DOI: 10.1016/j.ajic.2020.07.011

Henriques CMP, Vasconcelos W. Crises dentro da crise: respostas, incertezas e desencontros no combate à pandemia da COVID-19 no Brasil. Estud. av. 2020; 34(99): 25-44. DOI: 10.1590/s0103-4014.2020.3499.003

Abrams E, Szefler SJ. COVID-19 and the impact of social determinants of health. The Lancet Resp. Medicine. 2020; 8(7): 659-661. DOI: 10.1016/s2213-2600(20)30234-4

Tsai J, Wilson M. COVID-19: a potential public health problem for homeless populations. The Lancet Public Health. 2020; 5(4): 186-187. DOI: 10.1016/s2468-2667(20)30053-0

Niedzwiedz CL, O’Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al. Ethnic and socioeconomic diferences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Medicine. 2020; 18: 169. DOI: 10.1186/s12916-020-01640-8

Espírito Santo. Secretaria de Estado da Saúde do Espírito Santo. Painel COVID-19 – Estado do Espírito Santo. Vitória: Secretaria de Estado da Saúde do Espírito Santo; 2021.

Espírito Santo. Secretaria de Estado da Saúde do Espírito Santo. Plano Estadual de Saúde 2020-2023. Vitória: Secretaria de Estado da Saúde do Espírito Santo; 2019.

Espírito Santo. Secretaria de Estado da Saúde do Espírito Santo. Gerencia de Vigilância em Saúde. Nota técnica COVID-19 nº 73/2020 – GEVS/SESA/ES. Definição de Casos Operacionais e Critérios de Coleta. Vitória: Secretaria de Estado da Saúde do Espírito Santo; 2020.

Espírito Santo. Secretaria de Estado da Saúde do Espírito Santo. Gerencia de Vigilância em Saúde. Nota técnica COVID-19 nº 02/2021 – GEVS/SESA/ES. Definição de Casos Operacionais e Critérios de Coleta. Vitória: Secretaria de Estado da Saúde do Espírito Santo; 2021.

Maciel EL, Reis-Santos B. Determinants of tuberculosis in Brazil: from conceptual framework to practical application. Rev. Panam. Salud. Publica. 2015; 38(1): 28-34.

Shipe ME, Deppen AS, Farjah F, Grogon EL. Developing prediction models for clinical use using logistic regression: an overview. J Thorac Dis. 2019; 11(4): 574-84. DOI: 10.21037/jtd.2019.01.25

Cuschieri S, Grech S. At-risk population for COVID-19: multimorbidity characteristics of a European small Island state. Public Health. 2021; 192(1): 33-36. DOI: 10.1016/j.puhe.2020.12.012

Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, et al. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020; 75(9):1796-1800. DOI: 10.1093/gerona/glaa146

Millett GA, Jones AT, Benkeser D, Baral S, Mercer L, Beyrer C, et al. Assessing differential impacts of COVID-19 on black communities. Annals of Epidemiology. 2020; 47(1): 37-44. DOI: 10.1016/j.annepidem.2020.05.003

Palmieri L, Palmer K, Lo Noce C, Meli P, Giuliano M, Floridia M, et al. Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy. Aging Clin Exp Res. 2021; 33(1): 193–199. DOI: 10.1007/s40520-020-01764-0

Maciel EL, Jabor P, Goncalves Júnior E, Tristão-Sá R, Lima RCD, Reis-Santos B, et al. Fatores associados ao óbito hospitalar por COVID-19 no Espírito Santo, 2020. Epidemiol Serv Saúde. 2020; 29(4): e2020413. DOI: 10.1590/S1679-49742020000400022

Goes EF, Ramos DO, Ferreira AJF. Desigualdades raciais em saúde e a pandemia da Covid-19. Trab. Educ. Saúde. 2020; 18(3): e00278110. DOI: 10.1590/1981-7746-sol00278

Estrela FM, Soares CFS, Cruz MA, Silva AF, Santos JRL, Moreira TMO, et al. Pandemia da Covid 19: refletindo as vulnerabilidades a luz do gênero, raça e classe. Ciência & Saúde Coletiva. 2020; 25(9): 3431-3436. DOI: 10.1590/1413-81232020259.14052020

Ahmed F, Ahmed N, Pissarides C, Stiglitz J. Why inequality could spread COVID-19. The Lancet Public Health. 2020; 5(5): e240. DOI: 10.1016/S2468-2667(20)30085-2

Candido DS, Claro IM, Jesus JG, Souza WM, Moreira FRR, Dellicour S, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369(1): 1255-1260. DOI: 10.1126/science.abd2161

Albuquerque MV, Ribeiro LHL. Desigualdade, situação geográfica e sentidos da ação na pandemia da COVID-19 no Brasil. Cadernos de Saúde Pública. 2020; 36(12): e00208720. DOI: 10.1590/0102-311X00208720

Pilecco, FB, Coelho CG, Fernandes QHRF, Silveira IH, Pescarini JM, Ortelan N, et. al. Os efeitos da testagem laboratorial nos indicadores de acompanhamento da COVID-19: uma análise dos 50 países com maior número de casos. Epidemiol Serv Saúde. 2021; 30(2): e2020722. DOI: 10.1590/s1679-49742021000200002

Campos ACV, Leitão LPC. Letalidade da COVID-19 entre profissionais de saúde no Pará. Brasil. J Health NPEPS. 2021; 6(1): 22-34. DOI: 10.30681/252610105190

Fernandes FS, Toniasso SCC, Leitune JCB, Brum MCB, Leotti VB, Dantas Filho FF, et al. COVID-19 among healthcare workers in a Southern Brazilian Hospital and evaluation of a diagnostic strategy based on the RT-PCR test and retest for SARS-CoV-2. Eur Rev Med Pharmacol Sci. 2021; 25(8): 3365-3374. DOI: 10.26355/eurrev_202104_25748

Mascarello KC, Vieira ACB, Souza ASS, Marcarini WD, Barauna VG, Maciel ELN. Hospitalização e morte por COVID-19 e sua relação com determinantes sociais da saúde e morbidades no Espírito Santo: um estudo transversal. Epidemiol. Serv. Saúde. 2021; 30(3): e2020919. DOI: 10.1590/S1679-49742021000300004

Ghoraba MA, Albadi MA, Ibrahim AA, Alowais MM, Alqahtani GM, Alosaimi FA, et al. Clinical and demographic characteristics of patients with coronavirus disease 2019 in Security Forces Hospital, Riyadh, Saudi Arabia. J Family Med Prim Care. 2021; 10(2): 947-52. DOI: 10.4103/jfmpc.jfmpc_1484_20

Li SL, Pereira RHM, Prete CA Jr, Zarebski AE, Emanuel L, Alves PJH, et al. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Glob Health. 2021; 6(4): e004959. DOI: 10.1136/bmjgh-2021-004959

Maciel EL, Jabor PM, Goncalves E Jr, Siqueira PC, Prado TN, Zandonade E. Estudo da qualidade dos Dados do Painel COVID-19 para crianças, adolescente e jovens, Espírito Santo – Brasil, 2020. Esc. Anna Nery. 2021; 25(spe): e20200509. DOI: 10.1590/2177-9465-EAN-2020-0509

Published

2023-03-23

Issue

Section

ORIGINAL ARTICLES